BPC-157 vs LL-37

Overview

BPC-157 and LL-37 are both peptides of interest in tissue repair research but come from different origins and have distinct primary mechanisms. BPC-157 is a synthetic gastric peptide, while LL-37 is the only human cathelicidin antimicrobial peptide with both immune and wound healing properties.

Key Facts

Aspect	BPC-157	LL-37
Full Name	Body Protection Compound-157	Cathelicidin LL-37
Structure	15 amino acids	37 amino acids
Origin	Gastric juice (synthetic)	Human cathelicidin
Natural Occurrence	Derived from BPC	Naturally produced
FDA Status	Not approved	Not approved

Mechanism Comparison

Aspect	BPC-157	LL-37
Primary Function	Tissue repair (claimed)	Antimicrobial, immunomodulation
Secondary Function	Multiple claims	Wound healing
Antimicrobial	Not primary	Yes (broad spectrum)
Immune Effect	Not characterized	Well-documented

How They Work

BPC-157:

• Proposed to modulate NO system
• May enhance growth factor expression
• Claimed effects on tendon, muscle, GI
• Mechanism not fully elucidated

LL-37:

• Direct antimicrobial activity (membrane disruption)
• Modulates immune cell function
• Promotes angiogenesis
• Enhances wound healing
• Well-characterized mechanism

Evidence Comparison

Aspect	BPC-157	LL-37
Human Trials	1-2 (limited)	Some (various applications)
Research Groups	Primarily one	Multiple
Mechanism Studies	Limited	Extensive
Independent Replication	Limited	Yes

BPC-157 Research Concerns

• Majority from single research group
• Limited independent verification
• Mechanism poorly understood
• No active drug development

LL-37 Research Strength

• Well-characterized as human peptide
• Multiple research groups worldwide
• Clear antimicrobial mechanism
• Wound healing studies progressing

Biological Activities

BPC-157 Claimed Activities

Activity	Evidence Level
Tendon healing	Animal studies
Muscle repair	Animal studies
GI protection	Animal studies
Angiogenesis	Animal studies
Anti-inflammatory	Animal studies

LL-37 Activities

Activity	Evidence Level
Antimicrobial	Well-established
Wound healing	Human and animal
Angiogenesis	Demonstrated
Immunomodulation	Well-characterized
Anti-biofilm	Demonstrated

Applications in Research

Area	BPC-157	LL-37
Wound Healing	Claimed	Active research
Infection	Not used	Primary application
GI Conditions	Primary claim	Not primary
Burns	Limited	Research ongoing
Chronic Wounds	Claimed	Being studied

Safety Profile

BPC-157

Aspect	Information
Human Safety Data	Very limited
Long-term Effects	Unknown
Immunogenicity	Unknown
Quality Concerns	Significant (gray market)

LL-37

Aspect	Information
Human Safety Data	Some available
Natural Peptide	Endogenously produced
Immunogenicity	Low (human peptide)
Toxicity Concerns	At high concentrations

Regulatory Status

Aspect	BPC-157	LL-37
FDA Status	Not approved	Not approved
Drug Development	None active	Being explored
WADA Status	Prohibited	Not listed
Availability	Research chemical	Research chemical

Administration Routes

Route	BPC-157	LL-37
Injection (SC)	Common (research)	Research
Topical	Limited	More applicable
Oral	Claims exist	Not typical
Stability	Concerns	Challenging

Key Differences

Factor	BPC-157	LL-37
Origin	Synthetic (gastric)	Human (natural)
Primary Function	Tissue repair	Antimicrobial/immune
Mechanism Clarity	Low	High
Research Base	Limited	Extensive
Antimicrobial	No	Yes
Drug Development	None	Active interest

Practical Considerations

Choose BPC-157 for:

• GI-focused research (origin)
• Tendon/muscle claims
• Historical use in biohacking

Choose LL-37 for:

• Antimicrobial research
• Wound healing (evidence-based)
• Immunomodulation studies
• More rigorous research needs

Summary

• BPC-157 is a gastric-derived peptide with tissue repair claims but limited verified research
• LL-37 is a human antimicrobial peptide with well-characterized wound healing and immune effects
• LL-37 has stronger scientific foundation with multiple research groups
• BPC-157 research primarily from single group with limited replication
• LL-37 has potential therapeutic development pathway; BPC-157 has none
• Neither is FDA-approved; both available as research chemicals

---

This comparison is for educational purposes only. Neither peptide is approved for therapeutic use. Products sold as research chemicals have variable quality and safety is not established for human use.